AgeneBio, Inc.
PrivateLast Round
Grant
Sep 11, 2019
Total Funding Raised
$60.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AgeneBio, Inc. is a biotechnology company that develops therapeutics designed to preserve and restore brain function for patients with neurological and psychiatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AgeneBio, Inc. Comparables
Compare AgeneBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Damona Pharmaceuticals | 79% | |
| AriBio | 78% | |
| TauRx Pharmaceuticals | 77% |
AgeneBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 11, 2019 | ||||
| Series B | Nov 20, 2018 | ||||
| Grant | Oct 9, 2018 | ||||
| Grant | Sep 13, 2017 | ||||
| Grant | Jun 28, 2017 | ||||
Grant | Sep 15, 2015 |
AgeneBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant, Series A |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| National Institute on Aging | Grant |
| Johns Hopkins University Endowment | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 79% MoM.
- Mar 4, 2026
Monthly visitors increased 60% MoM.
AgeneBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AgeneBio, Inc.'s valuation, stock price, and market status.
Is AgeneBio, Inc. a public or private company?
AgeneBio, Inc. is a private company.
What is the current stock price of AgeneBio, Inc.?
AgeneBio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is AgeneBio, Inc. worth (valuation)?
Valuation information for AgeneBio, Inc. is not publicly available.
Can I buy AgeneBio, Inc. stock?
AgeneBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AgeneBio, Inc.'s last funding round?
Funding round information for AgeneBio, Inc. is not publicly available.
Who are the main investors in AgeneBio, Inc.?
Investor information for AgeneBio, Inc. is not publicly disclosed.
Will AgeneBio, Inc. IPO soon?
No public IPO plans have been announced for AgeneBio, Inc..
How can I track AgeneBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AgeneBio, Inc.'s secondary market activity and sign up for updates.